Recently merged CRO Clinipace raises $50M in new funding
Clinical research firm Clinipace, which recently merged with Shanghai-based dMed, has closed on $50 million in new funding from three primary backers.
Read More
Clinipace
Clinical research firm Clinipace looks to raise $10M, lands $4M so far from 10 investors
Clinical research firm Clinipace continues to raise cash, this time with a targeted amount of $10 million.
Read More
Morrisville-based Clinipace adds another $10.5M to its coffers, continues hiring spree
That brings its total raised to $14.7 million in a mix of as part of this round opened last October.
Read More
Morrisville-based Clinipace looks to raise $10M; 16 investors pour in $4.2M; it’s hiring, too
Clinical research organization Clinipace continues to raise cash, this time from 16 investors. And the firm hopes to raise abother $6 million.
Read More
CRO Clinipace adds to capital raising with another $4 million
Clinipace Inc., a contract research organization, has raised $4 million by selling private equity, according to a securities filing.
Read MoreClinipace Worldwide raises $5.7 million in a private-equity offering
Clinipace, a clinical research organization in Morrisville, has raised $5.7 million in a private equity offering
Read MoreMorrisville CRO Clinipace lands $10M in new equity
Morrisville-based contract research organization Clinipace, has raised $10 million in an equity raise from 16 investors, according to a regulatory filing. The company, which launched in 2003, is one of the larger CROs, with 800 employees. Clinipace has raised nearly $90 million in debt and equity since its founding. Jeff Williams, the co-founder and CEO at Clinipace Worldwide, who was head of the company for 14 years, stepped down in October 2017. Jason Monteleone, who recently launched a financial consulting firm but does have an extensive background in the life science industry, replaced him as CEO. The company handles regulatory...
Read More
